Fiche publication

Date publication

janvier 2023

Journal

Therapeutic advances in respiratory disease

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BONNIAUD Philippe


Tous les auteurs :
Guilleminault L, Camus C, Raherison-Semjen C, Capdepon A, Bourdin A, Bonniaud P, Fry S, Devouassoux G, Blanc FX, Pison C, Dupin C, Khayath N, Courdeau J, Valcke-Brossollet J, Nocent-Ejnaini C, Rolland F, Lamandi C, Proust A, Ozier A, Portel L, Gaspard W, Roux-Claude P, Beurnier A, Martinez S, Dot JM, Hennegrave F, Vignal G, Auvray E, Paleiron N, Just N, Miltgen J, Russier M, Olivier C, Taillé C, Didier A

Résumé

Biological therapies have revolutionized the treatment of severe asthma with type 2 inflammation. Although such treatments are very effective in reducing exacerbation and the dose of oral steroids, little is known about the persistence of symptoms in severe asthma patients treated with biologics.

Mots clés

biologics, healthcare, oral corticosteroid, quality of life, severe asthma

Référence

Ther Adv Respir Dis. 2023 ;17:17534666231202749

Fiche publication

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques